Safety and Immunogenicity of Typhoid Fever and Yellow Fever Vaccines When Administered Concomitantly With Quadrivalent Meningococcal ACWY Glycoconjugate Vaccine in Healthy Adults

ConclusionsThese data provide evidence that MenACWY‐CRM can be administered with typhoid Vi polysaccharide vaccine and live attenuated YF vaccine without compromising antibody responses stimulated by the individual vaccines. MenACWY‐CRM can, therefore, be incorporated into travelers' vaccination programs without necessitating an additional clinic visit (NCT01466387).

Source: Journal of Travel Medicine - September 1, 2014 Category: Infectious Diseases Authors: Martin Alberer, Gerd Burchard, Tomas Jelinek, Emil Reisinger, Jiri Beran, Lucie Cerna Hlavata, Eduardo Forleo‐Neto, Alemnew F. Dagnew, Ashwani K. Arora Tags: ORIGINAL ARTICLE Source Type: research